Mitsubishi acquiring NeuroDerm

By Julian Zhu | Jul 28, 2017 | 7:53 PM GMT

Mitsubishi Tanabe Pharma Corp. (Tokyo:4508) will acquire neurology company NeuroDerm Ltd. (NASDAQ:NDRM) for $1.1 billion at a price of $39

Read the full 203 word article

How to gain access

Continue reading with a
two-week free trial.